Average Co-Inventor Count = 6.98
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (13 from 1,537 patents)
2. Macrogenics, Inc. (6 from 130 patents)
13 patents:
1. 11884744 - Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof
2. 11680096 - Compound targeting IL-23A and TNF-alpha and uses thereof
3. 11267880 - Anti-Sema3A antibodies and their uses for treating eye or ocular diseases
4. 11242394 - Anti-CD40 antibodies
5. 10844138 - Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof
6. 10793629 - Compound targeting IL-23A and TNF-alpha and uses thereof
7. 10280231 - Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof
8. 10202448 - Anti-IL-23 antibodies
9. 10059763 - Compound targeting IL-23A and TNF-alpha and uses thereof
10. 9441036 - Anti-IL-23 antibodies
11. 9090696 - Polynucleotides encoding anti-CD40 antibodies
12. 8778346 - Anti-IL-23 antibodies
13. 8591900 - Anti-CD40 antibodies